Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Bison Capital Advisors, LLC

Bison Capital Advisors, LLC

CandidateSaint Louis, MOSEC exempt reporting adviser

no sworn venture fact yet (name or round mention only)

Importance
24
moderate
Active deployment
25
moderate
Emerging
0
low
Completeness
50
elevated
Freshness
97
high
Research priority
12
low
Identity and regulatory footprint
Headquarters
Saint Louis, MOadviserinfo.sec.gov
Office address
1750 S. BRENTWOOD BLVD, SUITE 403, Saint Louis, MO, 63144adviserinfo.sec.gov
Business phone
314-722-2215adviserinfo.sec.gov
Website
unknown
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
private fund adviseradviserinfo.sec.gov
Latest Form ADV
Mar 27, 2024
Private funds reported
32 (0 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$60.1Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business phone
314-722-2215adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
not stated or not yet read
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
32 reported, 4 no longer reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Acm-Kypha Convertible NoteFund · ADV: Private Equity Fund2024 adv first reportedEarly deployment$1.7M
Mar 27, 2024
13unknownunknown
Acm-Intershunt Convertible Note and Series BFund · ADV: Private Equity Fund2024 adv first reportedEarly deployment$569,000
Mar 27, 2024
7unknownunknown
Acm-Ideate Medical Partnership Tranche 5Fund · ADV: Private Equity Fund2024 adv first reportedEarly deployment$470,280
Mar 27, 2024
8unknownunknown
Acm-Oct Convertible Note PartnershipFund · ADV: Private Equity Fund2024 adv first reportedEarly deployment$338,000
Mar 27, 2024
5unknownunknown
Acm-Kypha Series BFund · ADV: Private Equity Fund2024 adv first reportedEarly deployment$253,000
Mar 27, 2024
2unknownunknown
Acm-Kypha Series a PartnershipFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$9.4M
Mar 27, 2024
24unknownunknown
Acm-Kypha Series Seed PartnershipSeed fund · ADV: Private Equity Fund2023 adv first reportedActive deployment$6.6M
Mar 27, 2024
34unknownunknown
ACM- Bonfyre Series A-1Fund · ADV: Private Equity Fund2023 adv first reportedActive deployment$5.6M
Mar 27, 2024
32unknownunknown
Acm-Harbor Medtech Series B PreferredFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$4.5M
Mar 27, 2024
25unknownunknown
Acm-Ideate Medical PartnershipFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$3.0M
Mar 27, 2024
4unknownunknown
Acm-Aptimmune Series aFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$2.7M
Mar 27, 2024
17unknownunknown
ACM- Aptimmune Series BFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$2.4M
Mar 27, 2024
13unknownunknown
Acm-Juristat A5Fund · ADV: Private Equity Fund2023 adv first reportedActive deployment$2.4M
Mar 27, 2024
12unknownunknown
ACM- Bonfyre Series A-2Fund · ADV: Private Equity Fund2023 adv first reportedActive deployment$2.2M
Mar 27, 2024
14unknownunknown
Acm-Kypha Series B-1Fund · ADV: Private Equity Fund2023 adv first reportedActive deployment$2.1M
Mar 27, 2024
14unknownunknown
Acm-Common Place HoldingsFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$2.0M
Mar 27, 2024
13unknownunknown
Acm-Juristat Series A-4Fund · ADV: Private Equity Fund2023 adv first reportedActive deployment$1.5M
Mar 27, 2024
8unknownunknown
Acm-Ideate Medical Part Tranche 3Fund · ADV: Private Equity Fund2023 adv first reportedActive deployment$1.3M
Mar 27, 2024
8unknownunknown
Acm-Juristat Series A-4aFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$1.1M
Mar 27, 2024
3unknownunknown
Acm-Wellopp Series B PartnershipFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$1.0M
Mar 27, 2024
13unknownunknown
ACM- Bonfyre Convertible NoteFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$856,750
Mar 27, 2024
5unknownunknown
ACM- Aptimmune Convertible Note PartnershipFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$815,000
Mar 27, 2024
9unknownunknown
Bonfyre Series aFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$750,000
Mar 27, 2024
8unknownunknown
Acm-Ideate Medical Part Tranche 2Fund · ADV: Private Equity Fund2023 adv first reportedActive deployment$689,385
Mar 27, 2024
4unknownunknown
Acm-Juristat Convertible NoteFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$667,300
Mar 27, 2024
2unknownunknown
Acm-Harbor Medtech Series C PreferredFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$573,750
Mar 27, 2024
13unknownunknown
Acm-Wellopp Convertible NoteFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$348,000
Mar 27, 2024
2unknownunknown
Acm-Wellopp Series B-1 PartnershipFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$323,750
Mar 27, 2024
3unknownunknown
Acm-Intershunt TechnologiesFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$300,000
Mar 27, 2024
6unknownunknown
Acm-Intershunt Technologies Series a PreferredFund · ADV: Private Equity Fund2023 adv first reportedActive deployment$115,000
Mar 27, 2024
3unknownunknown
Bison Capital Partners IV, LPFund2013 lp reportedHarvestunknownunknownunknownunknown
Ideate Medical Tranche IVFund · ADV: Private Equity FundunknownUnknown$350,000
Mar 27, 2024
6unknownunknown
Acm-Deck Commerce Seed PreferredSeed fund · ADV: Private Equity Fund2023 adv first reportedWound down$3.3M
Mar 28, 2023
14unknownunknown
Acm-Deck Commerce Convertible NoteFund · ADV: Private Equity Fund2023 adv first reportedWound down$2.9M
Mar 28, 2023
12unknownunknown
Acm-Deck Commerce Series aFund · ADV: Private Equity Fund2023 adv first reportedWound down$459,000
Mar 28, 2023
5unknownunknown
Acm-Deck Commerce A-2 PartnershipFund · ADV: Private Equity Fund2023 adv first reportedWound down$333,000
Mar 28, 2023
4unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
1 current, 0 departed
Peter Frederick Reinecke
Manager · since Nov 1, 2022
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
1 disclosed
Timeline
40 dated events
  1. Mar 27, 2024
    Acm-Deck Commerce Series a no longer reported on Form ADV by Bison Capital Advisors, LLC
    Fund no longer reportedFundsInferenceAcm-Deck Commerce Series aSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Mar 27, 2024
    Acm-Deck Commerce A-2 Partnership no longer reported on Form ADV by Bison Capital Advisors, LLC
    Fund no longer reportedFundsInferenceAcm-Deck Commerce A-2 PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Mar 27, 2024
    Acm-Kypha Series B first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $253,000
    Fund first reported on Form ADVFundsFactAcm-Kypha Series BSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Mar 27, 2024
    Acm-Oct Convertible Note Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $338,000
    Fund first reported on Form ADVFundsFactAcm-Oct Convertible Note PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Mar 27, 2024
    Acm-Intershunt Convertible Note and Series B first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $569,000
    Fund first reported on Form ADVFundsFactAcm-Intershunt Convertible Note and Series BSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  6. Mar 27, 2024
    Acm-Kypha Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,721,207
    Fund first reported on Form ADVFundsFactAcm-Kypha Convertible NoteSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  7. Mar 27, 2024
    Acm-Ideate Medical Partnership Tranche 5 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $470,280
    Fund first reported on Form ADVFundsFactAcm-Ideate Medical Partnership Tranche 5SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  8. Mar 27, 2024
    Acm-Deck Commerce Convertible Note no longer reported on Form ADV by Bison Capital Advisors, LLC
    Fund no longer reportedFundsInferenceAcm-Deck Commerce Convertible NoteSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  9. Mar 27, 2024
    Acm-Deck Commerce Seed Preferred no longer reported on Form ADV by Bison Capital Advisors, LLC
    Fund no longer reportedFundsInferenceAcm-Deck Commerce Seed PreferredSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  10. Mar 28, 2023
    Acm-Deck Commerce Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,887,500
    Fund first reported on Form ADVFundsFactAcm-Deck Commerce Convertible NoteSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  11. Mar 28, 2023
    Acm-Harbor Medtech Series C Preferred first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $573,750
    Fund first reported on Form ADVFundsFactAcm-Harbor Medtech Series C PreferredSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  12. Mar 28, 2023
    Acm-Ideate Medical Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,539,852
    Fund first reported on Form ADVFundsFactAcm-Ideate Medical PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  13. Mar 28, 2023
    Acm-Ideate Medical Part Tranche 2 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $590,586
    Fund first reported on Form ADVFundsFactAcm-Ideate Medical Part Tranche 2SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  14. Mar 28, 2023
    Acm-Aptimmune Series a first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,655,000
    Fund first reported on Form ADVFundsFactAcm-Aptimmune Series aSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  15. Mar 28, 2023
    Acm-Kypha Series a Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $9,377,000
    Fund first reported on Form ADVFundsFactAcm-Kypha Series a PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  16. Mar 28, 2023
    ACM- Bonfyre Series A-1 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $5,567,500
    Fund first reported on Form ADVFundsFactACM- Bonfyre Series A-1SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  17. Mar 28, 2023
    Acm-Ideate Medical Part Tranche 3 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,106,455
    Fund first reported on Form ADVFundsFactAcm-Ideate Medical Part Tranche 3SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  18. Mar 28, 2023
    Acm-Deck Commerce Seed Preferred first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $3,318,500
    Fund first reported on Form ADVFundsFactAcm-Deck Commerce Seed PreferredSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  19. Mar 28, 2023
    Acm-Kypha Series B-1 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,750,000
    Fund first reported on Form ADVFundsFactAcm-Kypha Series B-1SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  20. Mar 28, 2023
    Acm-Intershunt Technologies first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $300,000
    Fund first reported on Form ADVFundsFactAcm-Intershunt TechnologiesSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  21. Mar 28, 2023
    Acm-Deck Commerce A-2 Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $333,000
    Fund first reported on Form ADVFundsFactAcm-Deck Commerce A-2 PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  22. Mar 28, 2023
    Acm-Deck Commerce Series a first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $459,000
    Fund first reported on Form ADVFundsFactAcm-Deck Commerce Series aSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  23. Mar 28, 2023
    Acm-Harbor Medtech Series B Preferred first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $4,509,996
    Fund first reported on Form ADVFundsFactAcm-Harbor Medtech Series B PreferredSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  24. Mar 28, 2023
    ACM- Aptimmune Series B first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,255,000
    Fund first reported on Form ADVFundsFactACM- Aptimmune Series BSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  25. Mar 28, 2023
    Bonfyre Series a first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $750,000
    Fund first reported on Form ADVFundsFactBonfyre Series aSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  26. Mar 28, 2023
    ACM- Bonfyre Series A-2 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,207,875
    Fund first reported on Form ADVFundsFactACM- Bonfyre Series A-2SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  27. Mar 28, 2023
    Acm-Juristat Series A-4a first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,125,000
    Fund first reported on Form ADVFundsFactAcm-Juristat Series A-4aSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  28. Mar 28, 2023
    Acm-Juristat Series A-4 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,519,256
    Fund first reported on Form ADVFundsFactAcm-Juristat Series A-4SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  29. Mar 28, 2023
    Acm-Kypha Series Seed Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $6,600,000
    Fund first reported on Form ADVFundsFactAcm-Kypha Series Seed PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  30. Mar 28, 2023
    ACM- Aptimmune Convertible Note Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $815,000
    Fund first reported on Form ADVFundsFactACM- Aptimmune Convertible Note PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  31. Mar 28, 2023
    Acm-Common Place Holdings first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,000,000
    Fund first reported on Form ADVFundsFactAcm-Common Place HoldingsSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  32. Mar 28, 2023
    Acm-Intershunt Technologies Series a Preferred first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $115,000
    Fund first reported on Form ADVFundsFactAcm-Intershunt Technologies Series a PreferredSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  33. Mar 28, 2023
    Acm-Juristat A5 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,350,125
    Fund first reported on Form ADVFundsFactAcm-Juristat A5SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  34. Mar 28, 2023
    Acm-Juristat Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $667,300
    Fund first reported on Form ADVFundsFactAcm-Juristat Convertible NoteSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  35. Mar 28, 2023
    Acm-Wellopp Series B-1 Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $350,000
    Fund first reported on Form ADVFundsFactAcm-Wellopp Series B-1 PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  36. Mar 28, 2023
    ACM- Bonfyre Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $856,750
    Fund first reported on Form ADVFundsFactACM- Bonfyre Convertible NoteSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  37. Mar 28, 2023
    Acm-Wellopp Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $378,000
    Fund first reported on Form ADVFundsFactAcm-Wellopp Convertible NoteSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  38. Mar 28, 2023
    Acm-Wellopp Series B Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,139,500
    Fund first reported on Form ADVFundsFactAcm-Wellopp Series B PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  39. Dec 20, 2022
    Bison Capital Advisors, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  40. Dec 20, 2022
    Ideate Medical Tranche IV first reported on Form ADV by Bison Capital Advisors, LLC (Venture Capital Fund), GAV $251,850
    Fund first reported on Form ADVFundsFactIdeate Medical Tranche IVSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Candidate (candidate, 50%, cls-1)
    no sworn venture fact yet (name or round mention only)
Evidence
17 observations from 1 source
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedprivate_fund_adviserMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2022-12-20Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-03-27Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds0Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone314-722-2215Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersSaint Louis, MOMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address1750 S. BRENTWOOD BLVD, SUITE 403, Saint Louis, MO, 63144Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported32Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$60.1MMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture funds reported0Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)